interleukin-4 PE38KDEL cytotoxin
NBI-3001-0001
Phase 2 mab completed
Quick answer
interleukin-4 PE38KDEL cytotoxin for Brain and Central Nervous System Tumors is a Phase 2 program (mab) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEUROCRINE BIOSCIENCES INC
- Indication
- Brain and Central Nervous System Tumors
- Phase
- Phase 2
- Modality
- mab
- Status
- completed